2013
DOI: 10.2147/jaa.s38671
View full text
|
|
Share

Abstract: BackgroundThe purpose of this study was to evaluate the efficacy and duration of action of once-daily dosing with alcaftadine 0.25% ophthalmic solution and olopatadine 0.2% ophthalmic solution as compared with placebo in the prevention of ocular itching, and to directly compare the efficacy of alcaftadine 0.25% with olopatadine 0.2% in the prevention of ocular itching associated with allergic conjunctivitis using the conjunctival allergen challenge model.MethodsSubjects with allergic conjunctivitis (n = 127) w…

Expand abstract

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

2
40
0
3

Publication Types

Select...

Relationship

0
0

Authors

Journals